Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

0696 Lifestyle Factors in Narcolepsy and Idiopathic Hypersomnia

View through CrossRef
Abstract Introduction Narcolepsy and idiopathic hypersomnia (IH) are characterized by excessive daytime sleepiness. They can be caused by deficiency of orexin/hypocretin, a neuropeptide that regulates sleep and wakefulness. It is estimated that 1 in 2000 people in the United States of America have been diagnosed with some form of narcolepsy or idiopathic hypersomnia. Around the world, about 3 million people are narcoleptic. Little data are available regarding the lifestyle factors in these patients. In this study, we sought to find whether lifestyle factors, including diet and physical activity are associated with the severity of sleepiness in narcolepsy and idiopathic hypersomnia. Methods We collaborated with “Hypersomnia Foundation” and “Wake Up Narcolepsy” who distributed our survey to their subscribers. The survey consisted of a series of four short subsurveys asking about the substance use, diet (MiniEAT screen), exercise (IPAQ questionnaire), and daytime sleepiness (Epworth Sleepiness Scale). The survey was anonymous and included baseline characteristics, diagnosis (Narcolepsy type 1 (NT1), Narcolepsy type 2 (NT2), or Idiopathic Hypersomnia (IH)). We considered hypersomnolence and moderate to severe hypersomnolence to be present if ESS >10 and ≥15, respectively. Results We received total of 377 individual responses. Of those, 191 responders had IH, 97 had NT1 and 89 had NT2. Median age was 31 (25, 42) and 323 identified as females, 44 males and 10 others. Median ESS was 15 (12, 18), where 285 responders had ESS >10 (76%) and 194 (51%) had ESS >/=15. The ressponders with NT1 had significantly higher median ESS: 17 (12,19), than NT2: 15 (10, 17), or IH: 15(12, 17) responders (p< 0.01). In multiple univariate analyses, none of the baseline characteristics, habits (smoking, alcohol or caffeine), dietary consumption (fruit, vegetable, legumes/nuts/seeds, whole or refined grains, dairy and fish/seafood) or exercise (vigourous, moderate or walking) had significant association with the degree of responders’ subjective sleepiness. Conclusion Most survey responders continue to be excessively sleepy, particularly those with NT1. There were no apparent univariate associations of underlying hypersomnolence with the baseline characteristics, habits, diet and exercise levels. Disorders of central hypersomnolence are of complex nature without easily identifiable modifiers. Support (if any) Mayo Clinic CRISP
Oxford University Press (OUP)
Title: 0696 Lifestyle Factors in Narcolepsy and Idiopathic Hypersomnia
Description:
Abstract Introduction Narcolepsy and idiopathic hypersomnia (IH) are characterized by excessive daytime sleepiness.
They can be caused by deficiency of orexin/hypocretin, a neuropeptide that regulates sleep and wakefulness.
It is estimated that 1 in 2000 people in the United States of America have been diagnosed with some form of narcolepsy or idiopathic hypersomnia.
Around the world, about 3 million people are narcoleptic.
Little data are available regarding the lifestyle factors in these patients.
In this study, we sought to find whether lifestyle factors, including diet and physical activity are associated with the severity of sleepiness in narcolepsy and idiopathic hypersomnia.
Methods We collaborated with “Hypersomnia Foundation” and “Wake Up Narcolepsy” who distributed our survey to their subscribers.
The survey consisted of a series of four short subsurveys asking about the substance use, diet (MiniEAT screen), exercise (IPAQ questionnaire), and daytime sleepiness (Epworth Sleepiness Scale).
The survey was anonymous and included baseline characteristics, diagnosis (Narcolepsy type 1 (NT1), Narcolepsy type 2 (NT2), or Idiopathic Hypersomnia (IH)).
We considered hypersomnolence and moderate to severe hypersomnolence to be present if ESS >10 and ≥15, respectively.
Results We received total of 377 individual responses.
Of those, 191 responders had IH, 97 had NT1 and 89 had NT2.
Median age was 31 (25, 42) and 323 identified as females, 44 males and 10 others.
Median ESS was 15 (12, 18), where 285 responders had ESS >10 (76%) and 194 (51%) had ESS >/=15.
The ressponders with NT1 had significantly higher median ESS: 17 (12,19), than NT2: 15 (10, 17), or IH: 15(12, 17) responders (p< 0.
01).
In multiple univariate analyses, none of the baseline characteristics, habits (smoking, alcohol or caffeine), dietary consumption (fruit, vegetable, legumes/nuts/seeds, whole or refined grains, dairy and fish/seafood) or exercise (vigourous, moderate or walking) had significant association with the degree of responders’ subjective sleepiness.
Conclusion Most survey responders continue to be excessively sleepy, particularly those with NT1.
There were no apparent univariate associations of underlying hypersomnolence with the baseline characteristics, habits, diet and exercise levels.
Disorders of central hypersomnolence are of complex nature without easily identifiable modifiers.
Support (if any) Mayo Clinic CRISP.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study
Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study
Abstract Study Objectives Narcolepsy is associated with cardiovascular risk factors; however, the risk of new-onset cardiovascul...
503 Cardio-Vascular Burden of Narcolepsy Disease (CV-BOND): a Real-World Evidence Study
503 Cardio-Vascular Burden of Narcolepsy Disease (CV-BOND): a Real-World Evidence Study
Abstract Introduction Narcolepsy is a rare, lifelong disorder that requires long-term treatment and is associated with multiple ...
The case of inorganic hypersomnia treated with light therapy in the course of schizoaffective disorder
The case of inorganic hypersomnia treated with light therapy in the course of schizoaffective disorder
Abstract According to ICD 10, nonorganic hypersomnia is defined as “a condition of either excessive daytime sleepiness and sleep attacks (not accounted for by an ina...
Neurotransmitter Related Idiopathic Hypersomnia
Neurotransmitter Related Idiopathic Hypersomnia
Idiopathic hypersomnia affects 5% of the adult population, and both men and women are equally susceptible. Excessive sleep, sleep attacks, or wake-time delays are all examples of p...
Characterization of the Increase in Narcolepsy Following the 2009 H1N1 Pandemic in Sweden
Characterization of the Increase in Narcolepsy Following the 2009 H1N1 Pandemic in Sweden
In the context of the H1N1 pandemic and the Pandemrix vaccination campaign, an increased number of narcolepsy cases were noted in several countries. In Sweden, this phenomenon was...
Narcolepsy in Parkinson's disease with insulin resistance
Narcolepsy in Parkinson's disease with insulin resistance
Background: Parkinson’s disease (PD) is characterized by its progression of motor-related symptoms such as tremors, rigidity, slowness of movement, and difficul...
Narcolepsy in Parkinson's disease with insulin resistance
Narcolepsy in Parkinson's disease with insulin resistance
Background: Parkinson’s disease (PD) is characterized by its progression of motor-related symptoms such as tremors, rigidity, slowness of movement, and difficul...

Back to Top